Soaking ACL grafts in vancomycin solution (1 mg/ml) reduces the infection rate without increasing the risk for re-rupture and arthrofibrosis

Arch Orthop Trauma Surg. 2022 Jun;142(6):1141-1146. doi: 10.1007/s00402-021-04004-w. Epub 2021 Jul 3.

Abstract

Purpose: The aim of the present study was to evaluate if the vancomycin (1 mg/ml) is effective for the prevention of septic arthritis after ACL reconstruction. The hypothesis was that local antibiotic prophylaxis by soaking ACL grafts in vancomycin results in significantly less infections than ACL reconstruction without local antibiosis.

Methods: In group 1, 636 patients who were operated between 1.9.2014 and 31.8.2016 received no local antibiotic treatment with vancomycin. In group 2, 536 patients who were operated between 1.9.2016 and 31.8.2018 received local antibiotic treatment with vancomycin (1 mg/ml). In this group the graft was soaked in the vancomycin solution for 10 min prior to graft passage and fixation.

Results: In group 1 (ACL reconstruction without vancomycin application), a postoperative infection was detected in ten patients (infection rate: 1.6%). In group 2 (ACL reconstruction with 1 mg/ml vancomycin), no postoperative infection was detected (infection rate: 0%). The statistical analysis showed a clear significant difference between the two groups (p = 0.002). The re-rupture rate and the rate of arthrofibrosis differed not significantly between the two treatment groups (p = 0.526).

Conclusion: The results of the present study show that graft soaking in vancomycin (1 mg/ml) is effective for the prevention of septic arthritis after ACL reconstruction.

Level of evidence: III.

Keywords: ACL reconstruction; Antibiosis; Antibiotic prophylaxis; Graft failure; Infection staphylococcus; Knee infection; Septic arthritis.

MeSH terms

  • Anterior Cruciate Ligament Injuries* / etiology
  • Anterior Cruciate Ligament Injuries* / surgery
  • Anterior Cruciate Ligament Reconstruction* / methods
  • Anti-Bacterial Agents / therapeutic use
  • Arthritis, Infectious* / surgery
  • Humans
  • Joint Diseases* / etiology
  • Joint Diseases* / surgery
  • Postoperative Complications / etiology
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Vancomycin